Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cedars Sinai Medical Center

Founders Kaspare Cohn


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 15
Average round size
The average size of a deal this fund participated in
Portfolio companies 12
Rounds per year 0.12
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 3
Key employees Soon

Areas of investment

  • Health Care
  • Medical
  • Biotechnology
  • Health Diagnostics
  • Commercial

Cedars Sinai Medical Center appeared to be the Corporate Investor, which was created in 1902. The company was established in North America in United States. The main department of described Corporate Investor is located in the Los Angeles.

The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this Cedars Sinai Medical Center works on 0 percentage points less the average amount of lead investments. The important activity for fund was in 2019. The common things for fund are deals in the range of 5 - 10 millions dollars. Considering the real fund results, this Corporate Investor is 9 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2015.

The fund was created by Kaspare Cohn.

Among the most popular portfolio startups of the fund, we may highlight Capricor Therapeutics, Emulate, Health Care DataWorks. Among the most successful fund investment fields, there are Biotechnology, Wellness. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Cedars Sinai Medical Center, startups are often financed by The Cedars-Sinai Accelerator, Techstars, Techammer. The meaningful sponsors for the fund in investment in the same round are NanoDimension, Vertical Venture Partners, Techstars. In the next rounds fund is usually obtained by Techammer, OS Fund, National Institutes of Health.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Cedars Sinai Medical Center:
Typical Co-investors
Cedars Sinai Medical Center is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Cedars Sinai Medical Center:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AMI Opportunities Fund Israel, Tel Aviv, Tel Aviv District
Arnerich Massena & Associates Oregon, Portland, United States
Climb Ventures Geneva, Geneve, Switzerland
Evergreen Pacific Partners Seattle, United States, Washington
fullVenture Community of Madrid, Madrid, Spain
Ground Up Ventures New York, New York, United States
Harlan Capital Partners LLC New York, New York, United States
HealthInvest Equity Partners Connecticut, Stamford, United States
Heaven-Sent Capital Management Beijing, Beijing, China
LINICO Corporation Carson City, Nevada, United States
MEIF Proof-of-Concept & Early Stage Fund -
Natixis Private Equity France, Ile-de-France, Paris
Omega Media Norway, Oslo
SFJ Pharmaceuticals California, Pleasanton, United States
SIEGMUND Investment Company Germany, Thuringen, Thuringia
Teleios Investment Group Flat Rock, North Carolina, United States
Trinity Capital Investment Arizona, Phoenix, United States
U.S. Environmental Protection Agency District of Columbia, United States, Washington
Velt Partners Andalucia, Andalusia, Spain

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Visby Medical

Health Care
Health Diagnostics
$35M29 Jun 2022 San Jose, California, United States

Gemelli Biotech

Health Diagnostics
$19M22 Jun 2022 Raleigh, North Carolina, United States

Visby Medical

Health Care
Health Diagnostics
$100M01 Mar 2022 San Jose, California, United States


Health Care
$10M29 Jun 2021 London, England, United Kingdom

Prometheus Biosciences

Health Diagnostics
$130M09 Nov 2020 San Diego, California, United States

Visby Medical

Health Care
Health Diagnostics
$70M04 May 2020 San Jose, California, United States

Clinician Nexus

Health Care
$1M19 Dec 2019 Minneapolis, Minnesota, United States


Cyber Security
Health Care
Information Technology
Risk Management
Supply Chain Management
$7M22 Apr 2019 Boston, Massachusetts, United States


Health Care
$6M05 Mar 2019 Seattle, Washington, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cedars Sinai Medical Center?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: